Invivoscribe Submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to Support Daiichi Sankyo Submissions for Quizartinib
⟵ PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]
Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japan
⟵ PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]
Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations
⟵ PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]